purchase customization

1 Study Coverage
1.1 Conjugate Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Conjugate Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monovalent Conjugate Vaccines
1.2.3 Multivalent Conjugate Vaccines
1.3 Market by Application
1.3.1 Global Conjugate Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Conjugate Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Conjugate Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Conjugate Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Conjugate Vaccines Sales by Region
2.4.1 Global Conjugate Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Conjugate Vaccines by Region (2023-2028)
2.5 Global Conjugate Vaccines Revenue by Region
2.5.1 Global Conjugate Vaccines Revenue by Region (2017-2022)
2.5.2 Global Conjugate Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Conjugate Vaccines Sales by Manufacturers
3.1.1 Global Top Conjugate Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Conjugate Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Conjugate Vaccines in 2021
3.2 Global Conjugate Vaccines Revenue by Manufacturers
3.2.1 Global Conjugate Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Conjugate Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Conjugate Vaccines Revenue in 2021
3.3 Global Conjugate Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Conjugate Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Conjugate Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Conjugate Vaccines Sales by Type
4.1.1 Global Conjugate Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Conjugate Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Conjugate Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Conjugate Vaccines Revenue by Type
4.2.1 Global Conjugate Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Conjugate Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Conjugate Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Conjugate Vaccines Price by Type
4.3.1 Global Conjugate Vaccines Price by Type (2017-2022)
4.3.2 Global Conjugate Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Conjugate Vaccines Sales by Application
5.1.1 Global Conjugate Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Conjugate Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Conjugate Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Conjugate Vaccines Revenue by Application
5.2.1 Global Conjugate Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Conjugate Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Conjugate Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Conjugate Vaccines Price by Application
5.3.1 Global Conjugate Vaccines Price by Application (2017-2022)
5.3.2 Global Conjugate Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Conjugate Vaccines Market Size by Type
6.1.1 North America Conjugate Vaccines Sales by Type (2017-2028)
6.1.2 North America Conjugate Vaccines Revenue by Type (2017-2028)
6.2 North America Conjugate Vaccines Market Size by Application
6.2.1 North America Conjugate Vaccines Sales by Application (2017-2028)
6.2.2 North America Conjugate Vaccines Revenue by Application (2017-2028)
6.3 North America Conjugate Vaccines Market Size by Country
6.3.1 North America Conjugate Vaccines Sales by Country (2017-2028)
6.3.2 North America Conjugate Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Conjugate Vaccines Market Size by Type
7.1.1 Europe Conjugate Vaccines Sales by Type (2017-2028)
7.1.2 Europe Conjugate Vaccines Revenue by Type (2017-2028)
7.2 Europe Conjugate Vaccines Market Size by Application
7.2.1 Europe Conjugate Vaccines Sales by Application (2017-2028)
7.2.2 Europe Conjugate Vaccines Revenue by Application (2017-2028)
7.3 Europe Conjugate Vaccines Market Size by Country
7.3.1 Europe Conjugate Vaccines Sales by Country (2017-2028)
7.3.2 Europe Conjugate Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Conjugate Vaccines Market Size by Type
8.1.1 Asia Pacific Conjugate Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Conjugate Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Conjugate Vaccines Market Size by Application
8.2.1 Asia Pacific Conjugate Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Conjugate Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Conjugate Vaccines Market Size by Region
8.3.1 Asia Pacific Conjugate Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Conjugate Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Conjugate Vaccines Market Size by Type
9.1.1 Latin America Conjugate Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Conjugate Vaccines Revenue by Type (2017-2028)
9.2 Latin America Conjugate Vaccines Market Size by Application
9.2.1 Latin America Conjugate Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Conjugate Vaccines Revenue by Application (2017-2028)
9.3 Latin America Conjugate Vaccines Market Size by Country
9.3.1 Latin America Conjugate Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Conjugate Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Conjugate Vaccines Market Size by Type
10.1.1 Middle East and Africa Conjugate Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Conjugate Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Conjugate Vaccines Market Size by Application
10.2.1 Middle East and Africa Conjugate Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Conjugate Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Conjugate Vaccines Market Size by Country
10.3.1 Middle East and Africa Conjugate Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Conjugate Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Neuron Biotech
11.2.1 Neuron Biotech Corporation Information
11.2.2 Neuron Biotech Overview
11.2.3 Neuron Biotech Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Neuron Biotech Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Neuron Biotech Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Corporation Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Serum Institute of India Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Serum Institute of India Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sanofi Pasteur
11.5.1 Sanofi Pasteur Corporation Information
11.5.2 Sanofi Pasteur Overview
11.5.3 Sanofi Pasteur Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Pasteur Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Pasteur Recent Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Corporation Information
11.6.2 Bharat Biotech Overview
11.6.3 Bharat Biotech Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bharat Biotech Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Biotech Recent Developments
11.7 Biological
11.7.1 Biological Corporation Information
11.7.2 Biological Overview
11.7.3 Biological Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biological Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biological Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Overview
11.9.3 Merck Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 CSL
11.10.1 CSL Corporation Information
11.10.2 CSL Overview
11.10.3 CSL Conjugate Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CSL Conjugate Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Conjugate Vaccines Industry Chain Analysis
12.2 Conjugate Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Conjugate Vaccines Production Mode & Process
12.4 Conjugate Vaccines Sales and Marketing
12.4.1 Conjugate Vaccines Sales Channels
12.4.2 Conjugate Vaccines Distributors
12.5 Conjugate Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Conjugate Vaccines Industry Trends
13.2 Conjugate Vaccines Market Drivers
13.3 Conjugate Vaccines Market Challenges
13.4 Conjugate Vaccines Market Restraints
14 Key Findings in The Global Conjugate Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer